Author: Editor

IRS CEO Frank Bisignano discusses a report regarding staffing, higher refunds and the Trump Accounts on ‘Varney & Co.’ IRS CEO Frank Bisignano pushed back Monday on reports that the agency is short-staffed, telling FOX Business there is “no staffing shortage” and pointing to strong tax season performance as evidence. “That’s because people go, ‘If you had 100,000, and now you have 72,000, you must be short-staffed,'” Bisignano said on “Varney & Co.,” referencing a drop-off in the agency’s workforce.”But we’ve run orgs our whole life to drive productivity and quality, and it’s through technology,” he added. TRUMP TOUTS POTENTIAL…

In an aerial view, the Netflix logo is displayed above Netflix corporate offices on October 7, 2025 in Los Angeles, California.Mario Tama | Getty ImagesThere’s a love affair on Wall Street between investors and streaming.The romance started about a decade ago when consumers began cutting the cord with cable TV bundles en masse in favor of direct-to-consumer streaming apps. However, where investors were once enamored with subscriber growth, rewarding companies that were able to expand their consumer reach, their attentions have now shifted toward profitability.To meet this new expectation, streaming companies have raised the prices of their services, cracked down…

Goldman Sachs is getting an early look at one of the world’s most powerful AI models — and moving quickly to guard against the risks it could pose. Loading audio narration… CEO David Solomon said the bank is working closely with Anthropic to assess cybersecurity threats tied to its latest system, after the rollout raised alarms across the industry. Solomon said the bank is “hyperaware” of its capabilities and is coordinating with Anthropic and its own security vendors to guard against potential threats.Last week, Anthropic said it was not releasing its new model, Mythos, due to cybersecurity concerns. The company…

As tensions over the Strait of Hormuz raise the risk of oil market disruption, Goldman Sachs CEO David Solomon said Monday that the conflict in the Middle East has not yet slowed the dealmaking machine. Loading audio narration… “The environment for investment banking activity continues to be incredibly robust, particularly M&A activity,” Solomon said during the bank’s first-quarter earnings call, where Goldman reported about $17 billion in revenue. Nearly $13 billion came from its trading and investment banking division, including a 89% year-over-year surge in advisory revenue.But Solomon added that he didn’t “have a crystal ball” to predict how the…

President Trump speaks with reporters before departing on Marine One from the South Lawn of the White House on April 11 in Washington. Alex Brandon/AP hide caption toggle caption Alex Brandon/AP WASHINGTON — A federal judge dismissed President Trump’s $10 billion defamation lawsuit against the Wall Street Journal and Rupert Murdoch on Monday over a story on his ties to Jeffrey Epstein. U.S. District Judge Darrin P. Gayles in Florida wrote in the order that Trump had failed to make the argument that the article was published with the intent to be malicious, but gave the president a chance to…

Top Hollywood stars are speaking out against the Paramount-Warner Bros. Discovery deal. Loading audio narration… Over 1,000 Hollywood creatives published an open letter on Monday expressing “unequivocal opposition” to Paramount’s plan to buy WBD, which could close as soon as this fall if it gets regulatory approval.The Paramount-WBD tie-up “would further consolidate an already concentrated media landscape” and lead to “fewer opportunities for creators, fewer jobs across the production ecosystem, higher costs, and less choice for audiences in the United States and around the world,” the actors, directors, producers, and writers said in the letter.Among the signatories were household names…

IRS CEO Frank Bisignano discusses a report regarding staffing, higher refunds and the Trump Accounts on Varney & Co. The deadline to file 2025 tax returns is looming on Wednesday, April 15, and while tens of millions of taxpayers have filed their returns, there will likely be millions filing extensions to give themselves until the fall to submit their returns. Taxpayers who need more time to file their 2025 tax return can request an extension before the April 15 deadline by filling out an online form. Extensions give taxpayers until Oct. 15 to file their 2025 tax returns while avoiding a…

Whether you’re looking for a quick getaway or to plant roots overseas, there are plenty of places to choose from.To make that decision a little easier, Time Out surveyed more than 24,000 people across 150 cities and used their insights to rank cities worldwide by happiness, affordability, and quality of life. They also asked 100 Time Out city experts to weigh in to bolster their results.The survey questions went beyond recommendations for restaurants and nightlife and also sought to capture the feeling of living in each city.The result is a comprehensive list of diverse cities, some of which are known…

Delta A350 fleet renderings with the next-generation Delta One suite cabin.Courtesy: DeltaDelta Air Lines on Monday unveiled an updated Delta One suite for some of its longest-haul planes, marking its first refresh of the top-tier seat in a decade as airline competition for well-heeled travelers ramps up.The new suites, which Delta said will debut on its Airbus A350-1000 aircraft in 2027, will include beds that are three inches longer than the older suites and a new pillow-top cushion. The new design will give travelers more leg and knee room, said Mauricio Parise, Delta’s vice president of brand experience. “Most customers are side…

Pancreatic cancer, illustrationNemes Laszl | Science Photo Library | Getty ImagesRevolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of survival and slashing the risk of death by 60% versus chemotherapy, the company said Monday. RevMed said its daily pill, daraxonrasib, met all primary and secondary endpoints in a trial of people whose cancer had already progressed on another treatment. People who took daraxonrasib typically lived for 13.2 months versus 6.7 months for people who took chemotherapy, an increase of 6.5 months, RevMed said in a press release. “These are…